Protagonist Therapeutics, Inc
Price
FilingsNewest: 13G, Stake over 5%, passiveAug 7 →InsidersNo open-market buys. 7 insiders sold $47.2M, 5 of 31 sales on a 10b5-1 plan.→HoldersBlackRock 15.9%Farallon 9.8%RTW Investments 7.8%→PeersClosest companies: ALNY, INCY, ARWR→
From the filings
Figures
- Revenue
- $282.0Mlast 12 months
- Net income
- $82.9Mlast 12 months
- Operating cash flow
- −$116.6Mlast 12 months
- Cash and equivalents
- $420.1Mat the last balance sheet
- Shares outstanding
- 64.7M shareson issue